We are live on
!
Find out more
NFT
Nan Fung Trinity Portfolio holdings
AUM
$1.01B
1-Year Est. Return
64.38%
This Fund
S&P 500
This Quarter
Est. Return
+9.03%
1 Year Est. Return
+64.38%
3 Year Est. Return
+82.31%
5 Year Est. Return
+69.52%
10 Year Est. Return
–
AUM
$1.26B
AUM Growth
+$260M
(+26%)
Cap. Flow
+$231M
Cap. Flow
% of AUM
18.28%
Top 10 Holdings %
Top 10 Hldgs %
34.47%
Holding
89
New
18
Increased
31
Reduced
4
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$33.3M |
| 2 |
KT
KT
|
+$27.8M |
| 3 |
Advanced Micro Devices
AMD
|
+$19.9M |
| 4 |
MP Materials
MP
|
+$17.9M |
| 5 |
UnitedHealth
UNH
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$33.7M |
| 2 |
State Street SPDR S&P Bank ETF
KBE
|
+$23.1M |
| 3 |
Crown Holdings
CCK
|
+$16M |
| 4 |
MRUS
Merus
MRUS
|
+$14.2M |
| 5 |
Blackstone Secured Lending
BXSL
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.24% |
| 2 | Technology | 15.47% |
| 3 | Communication Services | 13.78% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Materials | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBVT
76
DBV Technologies
DBVT
$799M
| $711K | 0.06% |
37,095
| – | – |
|
77
Recursion Pharmaceuticals
RXRX
$1.59B
| $284K | 0.02% |
69,323
| – | – |
|
78
ALX Oncology
ALXO
$261M
| $47.4K | ﹤0.01% |
41,950
| – | – |
|
|
AKRO
79
DELISTED
Akero Therapeutics
AKRO
| – | – |
-110,650
| Closed | -$5.25M |
|
80
Ares Capital
ARCC
$13.5B
| – | – |
-604,000
| Closed | -$12.3M |
|
|
81
Blackstone Secured Lending
BXSL
$5.37B
| – | – |
-524,068
| Closed | -$13.7M |
|
|
82
Crown Holdings
CCK
$12.8B
| – | – |
-166,000
| Closed | -$16M |
|
83
Exelixis
EXEL
$13.3B
| – | – |
-34,200
| Closed | -$1.41M |
|
84
iQIYI
IQ
$1.23B
| – | – |
-1,801,450
| Closed | -$4.61M |
|
|
85
State Street SPDR S&P Bank ETF
KBE
$1.64B
| – | – |
-388,500
| Closed | -$23.1M |
|
|
86
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| – | – |
-531,800
| Closed | -$33.7M |
|
|
MRUS
87
DELISTED
Merus
MRUS
| – | – |
-150,338
| Closed | -$14.2M |
|
|
TRML
88
DELISTED
Tourmaline Bio
TRML
| – | – |
-227,090
| Closed | -$10.9M |
|
|
VRNA
89
DELISTED
Verona Pharma
VRNA
| – | – |
-76,320
| Closed | -$8.14M |
|
Similar funds
WA
GA
MAM
AG
BCM
EPAM
COI
CT
Nan Fung Trinity's Q4 2025 Portfolio in Review
As of Q4 2025, Nan Fung Trinity held 89 positions worth $1.26B, up 26% from $1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Nan Fung Trinity deployed $231M of net new capital in Q4 2025, opening 18 new positions and adding to 31 existing holdings. Its largest new stake was iShares MBS ETF: 349,200 shares worth $33.3M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 16% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Intel, an estimated $10.6M trimmed.
- Nan Fung Trinity's largest Q4 2025 buy was iShares MBS ETF: 349,200 shares worth $33.3M.
- Nan Fung Trinity added most to Advanced Micro Devices in Q4 2025, an estimated $19.9M increase.
- Nan Fung Trinity's biggest Q4 2025 reduction was Intel, cutting an estimated $10.6M.
- Nan Fung Trinity fully exited State Street SPDR S&P Regional Banking ETF in Q4 2025, selling an estimated $33.7M.
- Nan Fung Trinity's ten largest holdings make up 34% of its $1.26B portfolio in Q4 2025.
- Nan Fung Trinity opened 18 new positions and closed 11 in Q4 2025.
- Nan Fung Trinity's portfolio value rose 26% quarter-over-quarter to $1.26B.
Based on Nan Fung Trinity's 13F filing for Q4 2025, filed 4 Feb 2026.